Indole-3-Carbinol (I3C): Cruciferous Phytochemical for Estrogen Metabolism
⚡ 60-Second Summary
Indole-3-carbinol (I3C) is a phytochemical naturally produced when cruciferous vegetables — broccoli, kale, cauliflower, Brussels sprouts — are chopped or chewed. Enzymatic breakdown of glucobrassicin releases I3C, which then condenses in the acidic stomach environment to form diindolylmethane (DIM) and other condensation products.
Research has focused on estrogen metabolism, hormonal balance, cervical dysplasia, and cancer-preventive effects. The evidence is strongest for cervical health and estrogen metabolite ratios; anti-cancer evidence in humans is not sufficient to support treatment claims.
I3C converts to DIM in the body. Some researchers prefer DIM as a supplement because its pharmacology is better characterized. I3C and DIM are related but distinct, and their effects are not always interchangeable at supplement doses.
What is Indole-3-Carbinol (I3C)?
I3C increases the activity of CYP1A2 and other liver enzymes, shifting estrogen metabolism toward the 2-hydroxyestrone (2-OHE1) pathway rather than the 16α-hydroxyestrone pathway. A higher 2:16 estrogen metabolite ratio is associated with reduced breast cancer risk in epidemiological data, though causality has not been established.
I3C has also been studied for its direct actions: it can bind and activate the aryl hydrocarbon receptor (AhR), suppress NF-κB signaling, and induce apoptosis in cancer cell lines. These mechanisms are well-characterized in vitro but do not directly translate to anti-cancer treatment in humans.
Evidence-based benefits
Cervical dysplasia
Several small RCTs report regression of CIN (cervical intraepithelial neoplasia) grades I–II at 200–400 mg/day I3C; not sufficient to replace standard gynecological management.
Estrogen metabolite ratio (2:16)
Consistent evidence that supplemental I3C shifts urinary estrogen metabolites toward 2-OHE1; clinical significance of this shift is still debated.
Hormonal balance in women
Used in integrative medicine for PMS, fibrocystic breast, and estrogen-dominant conditions; evidence is limited and largely indirect.
Cancer prevention
Epidemiological association with cruciferous vegetable intake is strong; direct supplementation evidence for cancer prevention in humans is insufficient.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| I3C capsules/tablets | 200–400 mg/day | Standard supplement form | Converts to DIM in stomach; bioavailability is variable |
| DIM (diindolylmethane) | 100–200 mg/day | More stable metabolite | Preferred by some practitioners for better-characterized pharmacology |
| Cruciferous vegetable extracts | Varies | Whole-food matrix | Lower I3C dose but accompanied by other phytochemicals |
How much should you take?
- 200–400 mg/day in clinical trials for cervical dysplasia
- Take with food to facilitate acidic conversion to DIM
- Lower doses (100–200 mg) used in general hormone-support contexts
Clinical trial doses have ranged from 200 to 800 mg/day. Higher doses have shown more adverse effects including dizziness and headache. Women with hormone-sensitive cancers should discuss use with an oncologist before starting.
Safety and side effects
Common side effects
- Dizziness at higher doses
- Headache
- Rash (reported at high doses in some trials)
- GI discomfort
Serious risks
Because I3C influences estrogen metabolism and liver enzyme activity, it can alter drug metabolism. People with hormone-sensitive cancers, those on hormone therapy, or those taking medications metabolized by CYP1A2 or CYP3A4 should consult a clinician before use.
Drug and nutrient interactions
- Tamoxifen and aromatase inhibitors — I3C induces CYP3A4 and may accelerate tamoxifen metabolism, potentially reducing efficacy
- Warfarin and other CYP substrates — enzyme induction may alter drug levels
- Hormone therapy (estrogen, HRT) — I3C modifies estrogen metabolism; interaction is complex and person-specific
- Oral contraceptives — potential to alter hormone levels; use with caution
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Women with estrogen dominance or PMS | Reasonable to explore with medical guidance; strongest evidence is for cervical dysplasia |
| Women with hormone-sensitive cancer or on tamoxifen | Consult oncologist before use — possible CYP interaction could reduce drug efficacy |
| Men interested in testosterone or estrogen balance | Limited human evidence for men; DIM may be better characterized for this use |
| People on multiple medications | CYP enzyme induction risk is real; medication review before starting |
Frequently asked questions
What is the difference between I3C and DIM?
I3C is the precursor phytochemical; DIM (diindolylmethane) is its main active metabolite formed in the stomach. DIM has more stable and better-characterized pharmacology, but both are used in supplements.
Can I3C help with cervical dysplasia?
Small RCTs suggest possible benefit at 200–400 mg/day. It is not a replacement for standard gynecological monitoring and treatment of CIN.
Is I3C estrogenic or anti-estrogenic?
It is complex — I3C shifts estrogen metabolism but is neither purely estrogenic nor anti-estrogenic. The net effect depends on dose, individual enzyme activity, and hormonal context.
Can I3C interact with breast cancer medications?
Yes — I3C induces CYP3A4, which can accelerate metabolism of tamoxifen and potentially reduce its plasma levels. Discuss with your oncologist.
Should I take I3C or eat cruciferous vegetables?
Dietary cruciferous vegetables are safe and provide I3C along with fiber and other phytochemicals. Supplements provide higher, more concentrated doses, which carry more interaction risk.
Related ingredients
DIM (Diindolylmethane)
I3C's primary active metabolite; often preferred for hormone support
Curcumin
Anti-inflammatory phytochemical with overlapping NF-κB pathway effects
Resveratrol
Another phytochemical with hormonal and anti-cancer research
Quercetin
Antioxidant phytochemical with overlapping cancer-preventive research
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.